Immunome (IMNM) Amortization of Deferred Charges (2022 - 2026)
Immunome (IMNM) posted Amortization of Deferred Charges of $150000.0 for Q1 2026, up 2.04% on a QoQ basis from $147000.0 in Q4 2025, and up 30.43% year-over-year from $115000.0 in Q1 2025.
Immunome (IMNM) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Immunome's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $150000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges rose 30.43% year-over-year to $150000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $524000.0 (down 3.68% YoY) and the FY2025 annual result came in at $489000.0, down 8.6% from the prior year.
- Amortization of Deferred Charges was $150000.0 for Q1 2026 at Immunome, up from $147000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $165000.0 in Q4 2022 and bottomed at $8000.0 in Q2 2022.
- A 5-year average of $97294.1 and a median of $106000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- Peak annual rise in Amortization of Deferred Charges reached 600.0% in 2023, while the deepest fall reached 35.76% in 2023.
- Immunome's Amortization of Deferred Charges stood at $165000.0 in 2022, then plunged by 35.76% to $106000.0 in 2023, then surged by 36.79% to $145000.0 in 2024, then gained by 1.38% to $147000.0 in 2025, then increased by 2.04% to $150000.0 in 2026.
- Business Quant data shows IMNM's Amortization of Deferred Charges at $150000.0 in Q1 2026, $147000.0 in Q4 2025, and $144000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 147,000.00 |
| Dec 31, 2025 | 147,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Sep 30, 2024 | 160,000.00 |
| Sep 30, 2024 | 160,000.00 |
| Jun 30, 2024 | 124,000.00 |
| Jun 30, 2024 | 124,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 106,000.00 |
| Dec 31, 2023 | 106,000.00 |